Tel: (857) 239-0968 / (617) 419-7131
Home > HDAC
Cat.No. Product Name Information Area
T3983 TMP 195 Selective and cell-active class IIa histone deacetylase (HDAC) inhibitor, with IC50 v... Others
T3943 Butyric acid BUTYRIC ACID can react with oxidizing agents. Incandescent reactions occur with chrom... Others
T3516 Minomustine EDO-S101 is a pan HDAC inhibitor; inhibits HDAC1, HDAC2 and HDAC3 with IC50 values of... Others
T3509 ACY-738 ACY-738 demonstrates inhibitory activity against recombinant HDAC6 with IC50 values o... Others
T3937 Methyl L-histidinate dihydrochloride Inhibition of histidine decarboxylase in Sprague-Dawley rat stomach assessed as decre... Others
T3878 Raddeanin(Anemodeanin) A Raddeanin A has high antiangiogenic potency, antitumor activity. Raddeanin A has mode... Others
T3499 Remodelin Remodelin is a novel potent and selective inhibitor of the acetyl-transferase protein... Cancer
T6980 Scriptaid Scriptaid is an inhibitor of HDAC. It shows a greater effect on acetylated H4 than H3... Others
T3661 ACY-241 ACY-241, also known as Citarinostat, is a potent, selective and orally available hist... Cancer
T6865 Quisinostat (JNJ-26481585) 2HCl Quisinostat (JNJ-26481585) 2HCl is a novel second-generation HDAC inhibitor with high... Others
T6270 Trichostatin A (TSA) Trichostatin A (TSA) is an HDAC inhibitor with IC50 of ~1.8 nM – HDAC8 is the only kn... Cancer
T1558 Resveratrol Resveratrol is a phytoalexin produced naturally by several plants with anti-cancer, a... Cancer
T3205 UF010 UF010 is a potent and selective HADC inhibitor with IC50 ~0.06 μM, 0.1 μM, 0.5 μM and... Cancer
T3204 BML-210 BML-210 is the novel HDAC inhibitor, and its mechanism of action has not been charact... Cancer
T3199 PTACH PTACH (NCH-51) is a SAHA-based novel inhibitor of human HDAC. PTACH exerts potent gro... Cancer
T3193 Pimelic diphenylamide 106 Pimelic diphenylamide 106 is a slow, tight-binding inhibitor of class I HDAC (HDAC 1,... Cancer
T6639 RG2833 (RGFP109) RG2833 (RGFP109) is a brain-penetrant HDAC inhibitor with IC50 of 60 nM and 50 nM for... Cancer
T6421 BRD73954 BRD73954 ia a potent and selective HDAC inhibitor with IC50 of 36 nM and 120 nM for H... Cancer
T6362 4SC-202 free base 4SC-202 is a selective class I HDAC inhibitor with IC50 of 1.20 μM, 1.12 μM, and 0.57... Cancer
T6637 Resminostat Resminostat dose-dependently and selectively inhibits HDAC1/3/6 with IC50 of 42.5 nM/... Cancer
T6392 AR-42 AR-42 is an HDAC inhibitor with IC50 of 30 nM. Phase 1. Cancer
T6481 Droxinostat Droxinostat is a selective inhibitor of HDAC, mostly for HDACs 6 and 8 with IC50 of 2... Cancer
T6695 Tasquinimod Tasquinimod is an orally active antiangiogenic agent by allosterically inhibiting HDA... Cancer
T6233 Entinostat (MS-275) Entinostat (MS-275) strongly inhibits HDAC1 and HDAC3 with IC50 of 0.51 μM and 1.7 μM... Cancer
T6161 Tubastatin A hydrochloride Tubastatin A HCl is a potent and selective HDAC6 inhibitor with IC50 of 15 nM. It is ... Others
T6061 LMK-235 LMK-235 is a selective inhibitor of HDAC4 and HDAC5 with IC50 of 11.9 nM and 4.2 nM, ... Cancer
T6055 Quisinostat (JNJ-26481585) Quisinostat (JNJ-26481585) is a novel second-generation HDAC inhibitor with highest p... Cancer
T6006 Romidepsin (FK228, Depsipeptide)hot Romidepsin (FK228, depsipeptide) is a potent HDAC1 and HDAC2 inhibitor with IC50 of 3... Cancer
T3108 CUDC-101 CUDC-101 is a potent multi-targeted inhibitor against HDAC, EGFR and HER2 with IC50 o... Cancer
T2512 Mocetinostat Mocetinostat (MGCD0103) is a potent HDAC inhibitor with most potency for HDAC1 with I... Cancer